Save Ceftolozane/Tazobactam for Resistant E. coli or Pseudomonas

March 2015

Please see the FDA safety warning (May 2015) concerning dose confusion/medication errors associated with Zerbaxa

Reps will be promoting a new IV anti-infective, ceftolozane/tazobactam (Zerbaxa).

It's approved for complicated UTIs (cUTIs) and intra-abdominal infections (cIAIs) in adults. And higher doses are also being studied for ventilator-associated pneumonia.

Ceftolozane/tazobactam primarily covers gram-negative bacteria...including Pseudomonas and ESBL-producing Enterobacteriaceae.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Vaccines Ask Parents to Sign a "Refusal to Vaccinate" Form
Insulin Consider Afrezza as an Alternative to Mealtime Insulin Injections
Kidney Stones Use Doxazosin for Kidney Stones if Tamsulosin Isn't Available
Women's Health Save Opioids for Severe Pain During Pregnancy
Respiratory & Allergy Tell Patients All OTC and Rx Nasal Steroids Work About the Same
Anticoagulants Avoid Savaysa for A Fib if CrCl is OVER 95 mL/min
Rosacea Consider Soolantra for Rosacea if Metronidazole Isn't Enough
Psoriasis Be Aware Otezla May Be Safer Than Methotrexate for Plaque Psoriasis
Eating Disorders Consider Vyvanse for Adults Who Binge Eat More Than 3 Days Per Week
Readmissions See Patients Within 7 to 14 Days of Discharge to Prevent Readmissions
Diabetes Use Metformin in STABLE Kidney Disease
New Drugs Save Ceftolozane/Tazobactam for Resistant E. coli or Pseudomonas
Infectious Diseases Consider Steroids for CAP Patients on the Floor

Save Ceftolozane/Tazobactam for Resistant E. coli or Pseudomonas

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents